177548-00-4

Basic information

• Product Name: 1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)
• Synonyms: 1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE);1-Benzyl-1H-indole-4-carbonitrile
• CAS NO: 177548-00-4
• Molecular Formula: C₁₆H₁₂N₂
• Molecular Weight: 232.27988
• Mol File: 177548-00-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)(177548-00-4)
• EPA Substance Registry System: 1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)(177548-00-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 177548-00-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-benzyl-1H-indole-4-carbonitrile is used as a synthetic intermediate for the development of various pharmaceuticals. Its unique chemical structure, including the indole and carbonitrile groups, allows it to be a versatile building block in the creation of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-benzyl-1H-indole-4-carbonitrile serves as a key component in the design and synthesis of novel compounds with potential biological activities. Its presence in these compounds can influence their interactions with biological targets, such as enzymes or receptors, leading to the discovery of new therapeutic agents.
Used in Organic Synthesis:
1-benzyl-1H-indole-4-carbonitrile is utilized as a reagent in organic synthesis processes, where it can be further modified or combined with other molecules to create a wide range of organic compounds. Its versatility in organic synthesis makes it a valuable tool for chemists working on the development of new materials and compounds with specific properties.

Upstream product

• 16136-52-0 4-cyanoindole 
• 100-39-0 benzyl bromide 

Downstream Products

• 1345724-42-6 7-(1-benzyl-1H-indol-4-yl)-5-chloro-1,6-naphthyridine 
• 1345724-43-7 7-(1-benzyl-1H-indol-4-yl)-5-morpholin-4-yl-1,6-naphthyridine 
• 1404580-90-0 1-benzyl-3,3-difluoro-2-oxoindoline-4-carbonitrile 
• 3377-71-7 N-benzylindole 

Relevant articles and documents

Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease

Compounds of formulae (I) and (II): or a pharmaceutically acceptable salt thereof, wherein: R1 is a nitrogen-containing 5 to 7-membered heteroaryl or heterocycle; R2 and R3 are each independently (LQ)mY, are des

Nickel-catalyzed decyanation of inert carbon-cyano bonds

Nickel catalyzed decyanation of aryl and aliphatic cyanides with hydrosilane as the hydride source has been developed. This method is easy to handle, scalable and can be carried out without a glove box. The method has been applied in the cyanide directed functionalization reaction and α-substitution of benzyl cyanide.

NAPHTHRIDINE DERIVATIVES AS PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNE - INFLAMMATORY DISEASES

Compounds of formulae (I) and (II): or a pharmaceutically acceptable salt thereof, wherein: R1 is a nitrogen-containing 5 to 7-membered heteroaryl or heterocycle; R2 and R3 are each independently (LQ)mY, are des

PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND

Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.

Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer

Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.

Heterocyclic compounds, their preparation and their therapeutic use

A compound of formula (I): STR1 wherein Y1, Y2, Y3 and Y4 are each hydrogen, halogen, nitro, cyano, hydroxyl, thiol, amino, alkyl, haloalkyl, alkylthio, a protected or unprotected carboxyl, a protected or unprotected sulfonamide, or tetrazol; one of R1 and R2 is hydrogen, alkyl, aryl, aralkyl, oxazolyl, or a protected or unprotected carboxyl and the other of R1 and R2 is hydrogen, alkyl, aryl or aralkyl; and R3 is hydrogen or an amino protecting group, and pharmaceutically acceptable salts or esters thereof. The compounds are effective for treating dementia, Alzheimer's disease and delirium and are effective as sedatives.